Highlights from dyslipidemia research presented at the American Society for Preventive Cardiology 2026 Congress on Cardiovascular Disease Prevention, focusing on lipid-lowering therapies.

A data-driven design can optimize a VPP, identifying patients who can be served safely while seated in the emergency department (ED).

An umbrella review evaluates AI-based nursing interventions for chronic illness, finding potential benefits for predictive outcomes and care quality.

HealthDay News — Premature menopause is associated with a higher risk for developing hypertension, according to a study published online July 29 in Menopause.

Cardiovascular health scores in sexual and gender minority adults do not differ by gender identity or gender-affirming hormone therapy use.

Overview of 5 FDA Priority Review PDUFA decision dates in September 2026, covering novel treatments in rare neurological disorders, oncology, and adolescent cardiology.

Topline phase 3 ZEUS trial data show ziltivekimab failed to significantly reduce 3-point MACE risk in patients with ASCVD, CKD, and CV inflammation.

MNPs are detected significantly more frequently in patients with STEMI than in patients with CCS and controls with normal coronary arteries.

A preliminary injunction prompts the US Department of Education to include NP and PA programs under professional student loan limits.

The 2024-2025 US influenza vaccine provided moderate protection against outpatient illness, reducing medically attended visits by one-third.

Federal health officials have launched a nationwide clinical trial to find out whether a GLP-1 RA can help veterans cut back on drinking.

Many young adults may be entering adulthood without the skills needed to manage their own health care, according to a survey.